Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis
- PMID: 110697
- PMCID: PMC414310
- DOI: 10.1128/iai.24.2.363-370.1979
Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis
Abstract
Protein extracts were prepared from aerobically replicating cells of Mycobacterium tuberculosis and from synchronized non-replicating cells derived from the sediments of non-agitated cultures. Although both preparations share a number of antigens, the extracts of the non-replicating cells also contain antigenic components that are not shared by the replicating cells, and which can be isolated and visualized by immunoaffinity chromatography and immunoelectrophoretic techniques.
Similar articles
-
Comparative analysis of the antigens of M. tuberculosis H37RV with various mycobacterial antigens.Zentralbl Bakteriol Orig A. 1977;237(2-3):330-6. Zentralbl Bakteriol Orig A. 1977. PMID: 403715
-
Delayed hypersensitivity eliciting lipoprotein antigen of mycobacterium tuberculosis H37Rv.Indian J Med Res. 1982 Jul;76:10-7. Indian J Med Res. 1982. PMID: 6816727 No abstract available.
-
Immunoelectrophoretic analysis of antigenic constituents of Seibert fractions of mycobacterial culture filtrates. Identification with the proposed United States-Japan reference nomenclature.Am Rev Respir Dis. 1973 Nov;108(5):1244-8. doi: 10.1164/arrd.1973.108.5.1244. Am Rev Respir Dis. 1973. PMID: 4201018 No abstract available.
-
Early secretory antigenic target-6 of Mycobacterium tuberculosis: enigmatic factor in pathogen-host interactions.Microbes Infect. 2012 Nov;14(13):1220-6. doi: 10.1016/j.micinf.2012.07.019. Epub 2012 Aug 9. Microbes Infect. 2012. PMID: 22909901 Review.
-
The significance of proteins actively secreted by Mycobacterium tuberculosis in relation to immunity and complications of mycobacterial diseases.Int J Lepr Other Mycobact Dis. 1992 Sep;60(3):470-6. Int J Lepr Other Mycobact Dis. 1992. PMID: 1474286 Review. No abstract available.
Cited by
-
Mycobacterium bovis BCG response regulator essential for hypoxic dormancy.J Bacteriol. 2002 Dec;184(24):6760-7. doi: 10.1128/JB.184.24.6760-6767.2002. J Bacteriol. 2002. PMID: 12446625 Free PMC article.
-
MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis.Med Chem. 2009 Mar;5(2):197-207. doi: 10.2174/157340609787582882. Med Chem. 2009. PMID: 19275719 Free PMC article.
-
Dormancy of Mycobacterium tuberculosis and latency of disease.Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):908-14. doi: 10.1007/BF02111491. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7698116 Review.
-
Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog.J Bacteriol. 1996 Aug;178(15):4484-92. doi: 10.1128/jb.178.15.4484-4492.1996. J Bacteriol. 1996. PMID: 8755875 Free PMC article.
-
The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages.Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9578-83. doi: 10.1073/pnas.95.16.9578. Proc Natl Acad Sci U S A. 1998. PMID: 9689123 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources